tariquidar has been researched along with mitoxantrone in 3 studies
Studies (tariquidar) | Trials (tariquidar) | Recent Studies (post-2010) (tariquidar) | Studies (mitoxantrone) | Trials (mitoxantrone) | Recent Studies (post-2010) (mitoxantrone) |
---|---|---|---|---|---|
210 | 16 | 138 | 4,555 | 1,042 | 1,004 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benet, LZ; Brouwer, KL; Chu, X; Dahlin, A; Evers, R; Fischer, V; Giacomini, KM; Hillgren, KM; Hoffmaster, KA; Huang, SM; Ishikawa, T; Keppler, D; Kim, RB; Lee, CA; Niemi, M; Polli, JW; Sugiyama, Y; Swaan, PW; Tweedie, DJ; Ware, JA; Wright, SH; Yee, SW; Zamek-Gliszczynski, MJ; Zhang, L | 1 |
Chan, KF; Chan, TH; Chong, TC; Chow, LMC; Cui, J; Hu, X; Law, MC; Wong, ILK; Zhu, X | 1 |
Hanl, M; Marighetti, F; Steggemann, K; Wiese, M | 1 |
1 review(s) available for tariquidar and mitoxantrone
Article | Year |
---|---|
Membrane transporters in drug development.
Topics: Animals; Computer Simulation; Decision Trees; Drug Approval; Drug Discovery; Drug Evaluation, Preclinical; Drug Interactions; Humans; Membrane Transport Proteins; Mice; Mice, Knockout; Prescription Drugs | 2010 |
2 other study(ies) available for tariquidar and mitoxantrone
Article | Year |
---|---|
Triazole Bridged Flavonoid Dimers as Potent, Nontoxic, and Highly Selective Breast Cancer Resistance Protein (BCRP/ABCG2) Inhibitors.
Topics: 3T3 Cells; Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Computer Simulation; Copper; Dimerization; Drug Design; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flavones; Flavonoids; HEK293 Cells; Humans; Mice; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Triazoles | 2019 |
Synthesis and quantitative structure-activity relationships of selective BCRP inhibitors.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Drug Design; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Mitoxantrone; Neoplasm Proteins; Quantitative Structure-Activity Relationship; Quinolines | 2013 |